Works matching IS 00099236 AND DT 2020 AND VI 107 AND IP 4
Results: 51
Data Science in Clinical Pharmacology and Drug Development for Improving Health Outcomes in Patients.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 683, doi. 10.1002/cpt.1803
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 681, doi. 10.1002/cpt.1801
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 689, doi. 10.1002/cpt.1800
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 687, doi. 10.1002/cpt.1799
- Publication type:
- Article
An Introduction to Machine Learning.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 871, doi. 10.1002/cpt.1796
- By:
- Publication type:
- Article
Will Artificial Intelligence for Drug Discovery Impact Clinical Pharmacology?
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 780, doi. 10.1002/cpt.1795
- By:
- Publication type:
- Article
Emulation Differences vs. Biases When Calibrating Real‐World Evidence Findings Against Randomized Controlled Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 735, doi. 10.1002/cpt.1793
- By:
- Publication type:
- Article
Artificial Intelligence and Machine Learning: Will Clinical Pharmacologists Be Needed in the Next Decade? The John Henry Question.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 697, doi. 10.1002/cpt.1792
- By:
- Publication type:
- Article
"In‐House" Data on the Outside—A Mobile Health Approach.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 948, doi. 10.1002/cpt.1790
- By:
- Publication type:
- Article
An Application of Machine Learning in Pharmacovigilance: Estimating Likely Patient Genotype From Phenotypical Manifestations of Fluoropyrimidine Toxicity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 944, doi. 10.1002/cpt.1789
- By:
- Publication type:
- Article
MID3: Mission Impossible or Model‐Informed Drug Discovery and Development? Point‐Counterpoint Discussions on Key Challenges.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 762, doi. 10.1002/cpt.1788
- By:
- Publication type:
- Article
Development of a System for Postmarketing Population Pharmacokinetic and Pharmacodynamic Studies Using Real‐World Data From Electronic Health Records.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 934, doi. 10.1002/cpt.1787
- By:
- Publication type:
- Article
Integration of Omics Data Sources to Inform Mechanistic Modeling of Immune‐Oncology Therapies: A Tutorial for Clinical Pharmacologists.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 858, doi. 10.1002/cpt.1786
- By:
- Publication type:
- Article
Can We Rely on Results From IQVIA Medical Research Data UK Converted to the Observational Medical Outcome Partnership Common Data Model?: A Validation Study Based on Prescribing Codeine in Children.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 915, doi. 10.1002/cpt.1785
- By:
- Publication type:
- Article
Get Real: Integration of Real‐World Data to Improve Patient Care.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 722, doi. 10.1002/cpt.1784
- By:
- Publication type:
- Article
Pharmacokinetics and Pharmacodynamics of Intensive Antituberculosis Treatment of Tuberculous Meningitis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 1023, doi. 10.1002/cpt.1783
- By:
- Publication type:
- Article
Challenges in Alzheimer's Disease Drug Discovery and Development: The Role of Modeling, Simulation, and Open Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 796, doi. 10.1002/cpt.1782
- By:
- Publication type:
- Article
Data Science Approaches for Effective Use of Mobile Device–Based Collection of Real‐World Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 719, doi. 10.1002/cpt.1781
- By:
- Publication type:
- Article
Real‐World Data and Physiologically‐Based Mechanistic Models for Precision Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 694, doi. 10.1002/cpt.1780
- By:
- Publication type:
- Article
Open Data for Clinical Pharmacology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 703, doi. 10.1002/cpt.1779
- By:
- Publication type:
- Article
Virtual Twins: Understanding the Data Required for Model‐Informed Precision Dosing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 742, doi. 10.1002/cpt.1778
- By:
- Publication type:
- Article
Model‐Informed Artificial Intelligence: Reinforcement Learning for Precision Dosing.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 853, doi. 10.1002/cpt.1777
- By:
- Publication type:
- Article
Ability of Primary Care Health Databases to Assess Medicinal Products Discussed by the European Union Pharmacovigilance Risk Assessment Committee.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 957, doi. 10.1002/cpt.1775
- By:
- Publication type:
- Article
Pharmacometrics and Machine Learning Partner to Advance Clinical Data Analysis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 926, doi. 10.1002/cpt.1774
- By:
- Publication type:
- Article
Machine Learning for Cancer Drug Combination.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 749, doi. 10.1002/cpt.1773
- By:
- Publication type:
- Article
Regulatory Considerations for Building an In Silico Clinical Pharmacology Backbone by 2030.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 746, doi. 10.1002/cpt.1772
- By:
- Publication type:
- Article
Application of Machine Learning in Drug Development and Regulation: Current Status and Future Potential.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 726, doi. 10.1002/cpt.1771
- By:
- Publication type:
- Article
Small Models for Big Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 710, doi. 10.1002/cpt.1770
- By:
- Publication type:
- Article
Electronic Health Records for Drug Repurposing: Current Status, Challenges, and Future Directions.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 712, doi. 10.1002/cpt.1769
- By:
- Publication type:
- Article
Hippocampal Neuroimaging‐Informed Clinical Trial Enrichment Tool for Amnestic Mild Cognitive Impairment Using Open Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 903, doi. 10.1002/cpt.1766
- By:
- Publication type:
- Article
Scientific and Regulatory Considerations for an Ontogeny Knowledge Base for Pediatric Clinical Pharmacology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 707, doi. 10.1002/cpt.1763
- By:
- Publication type:
- Article
Analytic and Data Sharing Options in Real‐World Multidatabase Studies of Comparative Effectiveness and Safety of Medical Products.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 834, doi. 10.1002/cpt.1754
- By:
- Publication type:
- Article
Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 730, doi. 10.1002/cpt.1747
- By:
- Publication type:
- Article
Translational Knowledge Discovery Between Drug Interactions and Pharmacogenetics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 886, doi. 10.1002/cpt.1745
- By:
- Publication type:
- Article
Beyond the Randomized Clinical Trial: Innovative Data Science to Close the Pediatric Evidence Gap.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 786, doi. 10.1002/cpt.1744
- By:
- Publication type:
- Article
End Points, Collection, Processing, and Time: Four Key Elements to Consider When Planning for Use of Handheld Devices in a Drug Development Setting.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 715, doi. 10.1002/cpt.1740
- By:
- Publication type:
- Article
Open Models for Clinical Pharmacology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 700, doi. 10.1002/cpt.1738
- By:
- Publication type:
- Article
Changes in Manufacturing Processes of Biologic Therapies Can Alter the Immunogenicity Profile of the Product.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 988, doi. 10.1002/cpt.1694
- By:
- Publication type:
- Article
Exposure–Response Analyses of Upadacitinib Efficacy and Safety in Phase II and III Studies to Support Benefit–Risk Assessment in Rheumatoid Arthritis.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 994, doi. 10.1002/cpt.1671
- By:
- Publication type:
- Article
Examining the Use of Real‐World Evidence in the Regulatory Process.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 843, doi. 10.1002/cpt.1658
- By:
- Publication type:
- Article
Are Novel, Nonrandomized Analytic Methods Fit for Decision Making? The Need for Prospective, Controlled, and Transparent Validation.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 773, doi. 10.1002/cpt.1638
- By:
- Publication type:
- Article
Nonrandomized Real‐World Evidence to Support Regulatory Decision Making: Process for a Randomized Trial Replication Project.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 817, doi. 10.1002/cpt.1633
- By:
- Publication type:
- Article
Big Data – How to Realize the Promise.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 753, doi. 10.1002/cpt.1736
- By:
- Publication type:
- Article
A Machine‐Learning Approach to Identify a Prognostic Cytokine Signature That Is Associated With Nivolumab Clearance in Patients With Advanced Melanoma.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 978, doi. 10.1002/cpt.1724
- By:
- Publication type:
- Article
Beyond Randomized Clinical Trials: Use of External Controls.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 806, doi. 10.1002/cpt.1723
- By:
- Publication type:
- Article
Translational Informatics Connects Real‐World Information to Knowledge in an Increasingly Data‐Driven World.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 738, doi. 10.1002/cpt.1719
- By:
- Publication type:
- Article
Reproducing Protocol‐Based Studies Using Parameterizable Tools—Comparison of Analytic Approaches Used by Two Medical Product Surveillance Networks.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 966, doi. 10.1002/cpt.1698
- By:
- Publication type:
- Article
Single Therapeutic and Supratherapeutic Doses of Ubrogepant Do Not Affect Cardiac Repolarization in Healthy Adults: Results From a Randomized Trial.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 1014, doi. 10.1002/cpt.1696
- By:
- Publication type:
- Article
Dose‐Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 1004, doi. 10.1002/cpt.1695
- By:
- Publication type:
- Article
Choosing Among Common Data Models for Real‐World Data Analyses Fit for Making Decisions About the Effectiveness of Medical Products.
- Published in:
- Clinical Pharmacology & Therapeutics, 2020, v. 107, n. 4, p. 827, doi. 10.1002/cpt.1577
- By:
- Publication type:
- Article